Xanodyne Pharmaceuticals

Xanodyne Pharmaceuticals is a specialty pharmaceutical company that plans to raise $86.3 million in its initial public offering.

Fast Facts

1. Former name: UBE Pharmaceuticals
2. NASDAQ Stock symbol: XANO
3. Year Established: 2001, as UBE Pharmaceuticals
4. Industry: Pharmaceuticals; Pain management and women's health
5. Phone: 859-371-6383
6. Fax: 859-371-6391
7. HQ: Newport, Kentucky
8. President, CEO: Gregory D. Flexter
9. CFO: Stephen A. Stamp
10. Number of employees: 183
11. Products: Darvon, Darvocet, Oramorph SR, Roxicodone

Brief Description

Xanodyne Pharmaceuticals was founded in 2001 as UBE Pharmaceuticals, but changed to its current name in 2004. The company manufactures a variety of pain relief medications including the widely prescribed Darvon and Darvocet brands, as well as a Roxicodone line of products containing oxycodone. The company also has a line of prenatal vitamins, as well as a drug, XP12B, which is designed to reduce menstrual blood loss in women who suffer from excessive bleeding during menstruation.

Categories